Efficacy of Disulfiram for the Treatment of Alcohol Dependence Assessed with a Multicenter Randomized Controlled Trial

Alcoholism: Clinical and Experimental Research

Volumn 38, Issue 2, 2014, Pages 572-578

  Yoshimura, Atsushi ^a   Kimura, Mitsuru ^a   Nakayama, Hisakazu ^a   Matsui, Toshifumi ^a   Okudaira, Fukiko ^b   Akazawa, Shigeru ^c   Ohkawara, Masao ^d   Cho, Tetsuji ^e   Kono, Yoshihiro ^f   Hashimoto, Koji ^g   Kumagai, Masayuki ^h   Sahashi, Yukiko ⁱ   Roh, Sungwon ^j   Higuchi, Susumu ^a  

^a KURIHAMA NATIONAL HOSPITAL   (Japan)

^b Tohokukai Mental Hospital   (Japan)

^c Funabashi Central Hospital   (Japan)

^d Sumiyoshi Hospital Foundation   (Japan)

^e Mie Psychiatric Mental Care Center   (Japan)

^f Kanaoka Central Hospital   (Japan)

^g Koryo Hospital   (Japan)

^h Department of Psychiatry   (Japan)

ⁱ NATIONAL HOSPITAL ORGANIZATION YOKOHAMA MEDICAL CENTER   (Japan)

^j Seoul National University Hospital   (South Korea)

more..

Author keywords

Alcohol Dependence; ALDH2; Disulfiram; Efficacy; Randomized Controlled Trial

Indexed keywords

ALANINE AMINOTRANSFERASE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; ASPARTATE AMINOTRANSFERASE; DISULFIRAM; GAMMA GLUTAMYLTRANSFERASE; PLACEBO;

ADULT; AGED; AGORAPHOBIA; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL ABSTINENCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANOREXIA NERVOSA; ANTISOCIAL PERSONALITY DISORDER; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BULIMIA; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG EFFICACY; DRUG TREATMENT FAILURE; ENZYME ACTIVITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENERALIZED ANXIETY DISORDER; HOSPITALIZATION; HUMAN; JAPAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MANIA; MARRIAGE; OBSESSIVE COMPULSIVE DISORDER; OCCUPATION; OUTCOME ASSESSMENT; PANIC; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SOCIAL PHOBIA; SUICIDAL BEHAVIOR;

ALCOHOL DEPENDENCE; ALDH2; DISULFIRAM; EFFICACY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGE OF ONSET; AGED; ALCOHOL DETERRENTS; ALCOHOLISM; ALDEHYDE DEHYDROGENASE; DISULFIRAM; HOSPITALIZATION; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; JAPAN; KAPLAN-MEIER ESTIMATE; LIVER FUNCTION TESTS; MALE; MENTAL DISORDERS; MIDDLE AGED; SINGLE-BLIND METHOD; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84893648679     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12278     Document Type: Article

References (45)

1. Abajo P, Feal C, Sanz-Sanchez T, Sanchez-Perez J, Garcia-Diez A (1999) Eczematous erythroderma induced by cyanamide. Contact Dermatitis 40:160-161.
2. Ajima M, Usuki K, Igarashi A, Okazaki R, Hamano K, Urabe A, Totsuka Y (1997) Cyanamide-induced granulocytopenia. Intern Med 36:640-642.
3. Allsop S, Saunders B, Phillips M (2000) The process of relapse in severely dependent male problem drinkers. Addiction 95:95-106.
4. Anton RF, Moak DH, Latham P (1995) The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res 19:92-99.
5. Barth KS, Malcolm RJ (2010) Disulfiram: an old therapeutic with new applications. CNS Neurol Disord Drug Targets 9:5-12.
6. Boschloo L, Vogelzangs N, van den Brink W, Smit JH, Beekman AT, Penninx BW (2012) Predictors of the 2-year recurrence and persistence of alcohol dependence. Addiction 107:1639-1640.
7. Bottlender M, Soyka M (2005) Outpatient alcoholism treatment: predictors of outcome after 3 years. Drug Alcohol Depend 80:83-89.
8. Chick J (1999) Safety issues concerning the use of disulfiram in treating alcohol dependence. Drug Saf 20:427-435.
9. Chick J, Gough K, Falkowski W, Kershaw P, Hore B, Mehta B, Ritson B, Ropner R, Torley D (1992) Disulfiram treatment of alcoholism. Br J Psychiatry 161:84-89.
10. De Sousa A (2004) A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence. Alcohol Alcohol 39:528-531.
11. De Sousa A (2005) An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence. Alcohol Alcohol 40:545-548.
12. De Sousa A, De Sousa A (2009) An open randomized study comparing disulfiram and naltrexone in adolescents with alcohol dependence. J Subst Use 13:382-388.
13. De Sousa A, De Sousa J, Kapoor H (2008) An open randomized trial comparing disulfiram and topiramate in the treatment of alcohol dependence. J Subst Abuse Treat 34:460-463.
14. Deane FP, Wootton DJ, Hsu CI, Kelly PJ (2012) Predicting dropout in the first 3 months of 12-step residential drug and alcohol treatment in an Australian sample. J Stud Alcohol Drugs 73:216-225.
15. Drobes DJ, Thomas SE (1999) Assessing craving for alcohol. Alcohol Res Health 23:179-186.
16. Eng MY, Luczak SE, Wall TL (2007) ALDH2, ADH1B, and ADH1C genotypes in Asians: a literature review. Alcohol Res Health 30:22-27.
17. Friedmann PD, Saitz R, Samet JH (1998) Management of adults recovering from alcohol or other drug problems: relapse prevention in primary care. JAMA 279:1227-1231.
18. Fuller RK, Branchey L, Brightwell DR, Derman RM, Emrick CD, Iber FL, James KE, Lacoursiere RB, Lee KK, Lowenstam I, Maany I, Neiderhiser D, Nocks JJ, Shaw S (1986) Disulfiram treatment of alcoholism. A Veterans Administration cooperative study. JAMA 256:1449-1455.
19. Fuller RK, Gordis E (2004) Does disulfiram have a role in alcoholism treatment today? Addiction 99:21-24.
20. Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT (1999) Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA 281:1318-1325.
21. Gastfriend DR, Garbutt JC, Pettinati HM, Forman RF (2007) Reduction in heavy drinking as a treatment outcome in alcohol dependence. J Subst Abuse Treat 33:71-80.
22. Glenn SW, Parsons OA (1991) Prediction of resumption of drinking in posttreatment alcoholics. Int J Addict 26:237-254.
23. Gordon SM, Sterling R, Siatkowski C, Raively K, Weinstein S, Hill PC (2006) Inpatient desire to drink as a predictor of relapse to alcohol use following treatment. Am J Addict 15:242-245.
24. Harada S, Agarwal DP, Goedde HW (1981) Aldehyde dehydrogenase deficiency as cause of facial flushing reaction to alcohol in Japanese. Lancet 2:982.
25. Harada S, Agarwal DP, Goedde HW, Tagaki S, Ishikawa B (1982) Possible protective role against alcoholism for aldehyde dehydrogenase isozyme deficiency in Japan. Lancet 2:827.
26. Higuchi S, Matsushita S, Imazeki H, Kinoshita T, Takagi S, Kono H (1994) Aldehyde dehydrogenase genotypes in Japanese alcoholics. Lancet 343:741-742.
27. Higuchi S, Matsushita S, Muramatsu T, Murayama M, Hayashida M (1996) Alcohol and aldehyde dehydrogenase genotypes and drinking behavior in Japanese. Alcohol Clin Exp Res 20:493-497.
28. Higuchi S, Matsushita S, Murayama M, Takagi S, Hayashida M (1995) Alcohol and aldehyde dehydrogenase polymorphisms and the risk for alcoholism. Am J Psychiatry 152:1219-1221.
29. Hughes JC, Cook CC (1997) The efficacy of disulfiram: a review of outcome studies. Addiction 92:381-395.
30. Jørgensen CH, Pedersen B, Tønnesen H (2011) The efficacy of disulfiram for the treatment of alcohol use disorder. Alcohol Clin Exp Res 35:1749-1758.
31. Krampe H, Ehrenreich H (2010) Supervised disulfiram as adjunct to psychotherapy in alcoholism treatment. Curr Pharm Des 16:2076-2090.
32. Niederhofer H, Staffen W (2003) Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents. Drug Alcohol Rev 22:295-297.
33. Niederhofer H, Staffen W, Mair A (2003) Comparison of cyanamide and placebo in the treatment of alcohol dependence of adolescents. Alcohol Alcohol 38:50-53.
34. Owen P, Marlatt GA (2001) Should abstinence be the goal for alcohol treatment? Affirmative viewpoint. Am J Addict 10:289-291; discussion 294-285.
35. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):22-33; quiz 34-57.
36. Skinner HA, Allen BA (1982) Alcohol dependence syndrome: measurement and validation. J Abnorm Psychol 91:199-209.
37. Suzuki Y, Yokoyama A, Nakano M, Okuyama K, Takahashi H, Tamai H, Maruyama K, Ishii H (2000) Cyanamide-induced liver dysfunction after abstinence in alcoholics: a long-term follow-up study on four cases. Alcohol Clin Exp Res 24:100S-105S.
38. Tamai H, Yokoyama A, Okuyama K, Takahashi H, Maruyama K, Suzuki Y, Ishii H (2000) Comparison of cyanamide and disulfiram in effects on liver function. Alcohol Clin Exp Res 24:97S-99S.
39. Turkcapar H, Kose S, Ince A, Myrick H (2005) Beliefs as a predictor of relapse in alcohol-dependent Turkish men. J Stud Alcohol 66:848-851.
40. Ulrichsen J, Nielsen MK, Ulrichsen M (2010) Disulfiram in severe alcoholism-an open controlled study. Nord J Psychiatry 64:356-362.
41. Vielva I, Iraurgi I (2001) Cognitive and behavioural factors as predictors of abstinence following treatment for alcohol dependence. Addiction 96:297-303.
42. Witkiewitz K (2011) Predictors of heavy drinking during and following treatment. Psychol Addict Behav 25:426-438.
43. World Health Organization (1992) The International Classification of Diseases in Series The International Classification of Diseases. World Health Organization, Geneva.
44. Yerro CP, Lopez CP, Bernardino AR, Martinez RM, del Potro Gomez E, Carmona AA (2000) Relapsing pancytopenia following exposure and re-exposure to cyanamide. Eur J Haematol 65:414-415.
45. Yokoyama A, Sato S, Maruyama K, Nakano M, Takahashi H, Okuyama K, Takagi S, Takagi T, Yokoyama T, Hayashida M, Ishii H (1995) Cyanamide-associated alcoholic liver disease: a sequential histological evaluation. Alcohol Clin Exp Res 19:1307-1311.